Wall Street is positive on Tandem Diabetes Care Inc (TNDM). On average, analysts give Tandem Diabetes Care Inc a Buy rating. The average price target is $119.4, which means analysts expect the stock to decline by -9.61% over the next twelve months.
That average ranking earns Tandem Diabetes Care Inc an Analyst Rating of 15, which is better than 15% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating TNDM a Buy today. Find out what this means to you and get the rest of the rankings on TNDM!
Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported.
InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.
What's Happening With Tandem Diabetes Care Inc Stock Today?
Tandem Diabetes Care Inc (TNDM) stock is trading at $132.10 as of 1:49 PM on Wednesday, Oct 13, an increase of $1.74, or 1.33% from the previous closing price of $130.36. The stock has traded between $130.48 and $133.00 so far today. Volume today is low. So far 194,790 shares have traded compared to average volume of 985,151 shares.
Click Here to get the full Stock Report for Tandem Diabetes Care Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
